Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: IRD001
MIFTS: 40

Iridocyclitis

Categories: Eye diseases
Genes Tissues Related diseases Publications Pathways Drugs
Sources

Aliases & Classifications for Iridocyclitis

About this section

MalaCards integrated aliases for Iridocyclitis:

Name: Iridocyclitis 12 76 55 44 15 73
Primary Iridocyclitis 12 73

Classifications:

MalaCards categories:
Anatomical: Eye diseases
See all MalaCards categories (disease lists)
ICD10: 33


External Ids:

Disease Ontology 12 DOID:9383
ICD9CM 35 364.01 364.2
MeSH 44 D015863
SNOMED-CT 68 12630008
Sources

Summaries for Iridocyclitis

About this section
MalaCards based summary : Iridocyclitis, also known as primary iridocyclitis, is related to fuchs' heterochromic uveitis and juvenile rheumatoid arthritis. An important gene associated with Iridocyclitis is DEK (DEK Proto-Oncogene), and among its related pathways/superpathways are Influenza A and Epstein-Barr virus infection. The drugs Adalimumab and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and testes.

Wikipedia : 76 Uveitis is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the... more...

Sources

Related Diseases for Iridocyclitis

About this section

Diseases related to Iridocyclitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 102)
# Related Disease Score Top Affiliating Genes
1 fuchs' heterochromic uveitis 33.5 CYP11B1 MRAP
2 juvenile rheumatoid arthritis 30.5 DEK HLA-DPB1
3 iritis 30.0 HLA-B MRAP
4 rubella 29.9 HLA-B HLA-DPB1
5 spondyloarthropathy 1 29.6 HLA-B MRAP
6 glaucomatocyclitic crisis 29.2 CYP11B1 HLA-B HLA-DPB1 MRAP
7 lens-induced iridocyclitis 12.2
8 gonococcal iridocyclitis 12.1
9 infectious anterior uveitis 11.7
10 anterior uveitis 11.6
11 phacoanaphylactic uveitis 11.5
12 retinal vasculitis 11.1
13 uveitis 10.8
14 arthritis 10.5
15 idiopathic anterior uveitis 10.5
16 rheumatoid arthritis 10.4
17 cataract 10.4
18 herpes simplex 10.2
19 vogt-koyanagi-harada disease 10.2
20 diffuse infiltrative lymphocytosis syndrome 10.1 MRAP TNFRSF10B
21 chikungunya 10.1
22 hypopyon 10.1
23 toxoplasmosis 10.1
24 palindromic rheumatism 10.1 MRAP TNFRSF10B
25 iris disease 10.0 CRYAA MRAP
26 uveal disease 10.0 HLA-B MRAP
27 byssinosis 10.0 HLA-DPB1 MRAP
28 spondyloarthropathy 10.0 HLA-B MRAP
29 geographic tongue 10.0 HLA-B TNFRSF10B
30 retinitis 10.0
31 syphilis 10.0
32 conjunctivitis 10.0
33 psoriasis 10.0
34 ocular toxoplasmosis 10.0
35 behcet syndrome 9.9 HLA-B MRAP TNFAIP3
36 panuveitis 9.9 CYP11B1 HLA-B MRAP
37 astigmatism 9.9
38 pars planitis 9.9
39 psoriatic arthritis 9.9
40 keratoconus 9.9
41 secondary syphilis 9.9
42 endophthalmitis 9.9
43 spondylitis 9.9
44 meningitis 9.9
45 takayasu arteritis 9.9 HLA-B HLA-DPB1
46 systemic lupus erythematosus 9.8
47 leprosy 3 9.8
48 retinitis pigmentosa 9.8
49 leber congenital amaurosis 4 9.8
50 allergic rhinitis 9.8

Graphical network of the top 20 diseases related to Iridocyclitis:



Diseases related to Iridocyclitis
Sources

Symptoms & Phenotypes for Iridocyclitis

About this section
Sources

Drugs & Therapeutics for Iridocyclitis

About this section

Drugs for Iridocyclitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 109)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
2
Ganciclovir Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 82410-32-0 3454
3
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
4
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
5
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
6
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
7
Acyclovir Approved Phase 4,Phase 3 59277-89-3 2022
8
leucovorin Approved Phase 4,Not Applicable 58-05-9 6006 143
9
Methotrexate Approved Phase 4,Not Applicable 59-05-2, 1959-05-2 126941
10
Dinoprost Tromethamine Approved, Vet_approved Phase 4 38562-01-5 5282415
11
Bimatoprost Approved, Investigational Phase 4 155206-00-1 5311027
12
Dinoprost Approved, Investigational Phase 4 551-11-1 5283078
13
Difluprednate Approved Phase 4,Phase 3,Phase 2 23674-86-4 443936
14
Certolizumab pegol Approved Phase 4,Phase 3 428863-50-7
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 59-30-3 6037
16
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2920-86-7
17 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
21 Antirheumatic Agents Phase 4,Phase 3,Not Applicable
22 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Ganciclovir triphosphate Phase 4,Phase 2,Phase 3,Not Applicable
24 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Not Applicable
25 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
26 Immunologic Factors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
27 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Vitamin B9 Phase 4,Not Applicable
31 Antimetabolites Phase 4,Not Applicable
32 Antimetabolites, Antineoplastic Phase 4,Not Applicable
33 Folic Acid Antagonists Phase 4,Not Applicable
34 Vitamin B Complex Phase 4,Not Applicable
35 Folate Phase 4,Not Applicable
36 Dermatologic Agents Phase 4,Phase 3,Not Applicable
37 beta-endorphin Phase 4,Not Applicable
38 Adrenocorticotropic Hormone Phase 4,Not Applicable
39 Melanocyte-Stimulating Hormones Phase 4,Not Applicable
40 Lubricant Eye Drops Phase 4
41 Antihypertensive Agents Phase 4
42 Benzalkonium Compounds Phase 4,Phase 3
43 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
44 Anti-Infective Agents, Local Phase 4,Phase 3
45 Oxytocics Phase 4
46 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 valacyclovir Phase 4
48
Ranibizumab Approved Phase 2, Phase 3 347396-82-1 459903
49
Etanercept Approved, Investigational Phase 3,Not Applicable 185243-69-0
50
Fluprednisolone Approved Phase 3,Phase 2 53-34-9

Interventional clinical trials:

(show top 50) (show all 67)
# Name Status NCT ID Phase Drugs
1 Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Completed NCT02764697 Phase 4 H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
2 Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Completed NCT02059655 Phase 4 Bimatoprost;Eye drop solution
3 A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment Completed NCT02897115 Phase 4
4 Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis Recruiting NCT02943057 Phase 4 2% guttae ganciclovir
5 A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU Active, not recruiting NCT03020992 Phase 4 Certolizumab Pegol
6 A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis Not yet recruiting NCT03626376 Phase 4 oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily;oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
7 Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Terminated NCT02769702 Phase 4 Acthar
8 Methotrexate in the Treatment of Axial Spondyloarthritis Withdrawn NCT00298012 Phase 4 Methotrexate
9 Herpetic Eye Disease Study (HEDS) I Unknown status NCT00000138 Phase 3 Prednisolone Phosphate;Acyclovir
10 Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy Unknown status NCT02769169 Phase 2, Phase 3 Lucentis® (Raibizumab) double-dose;Lucentis® (Raibizumab) regular-dose
11 Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Completed NCT01201798 Phase 3 Difluprednate 0.05% ophthalmic emulsion;Prednisolone acetate 1.0% ophthalmic suspension
12 A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis Completed NCT00404885 Phase 3 Placebo;LX211;LX211;LX211
13 Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis Completed NCT02517619 Phase 3 Dexamethasone Phosphate Ophthalmic Solution;Prednisolone Acetate Ophthalmic (1%)
14 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed NCT00406887 Phase 3 Difluprednate Ophthalmic Emulsion
15 Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis Completed NCT01505088 Phase 3 40 mg/mL Dexamethasone phosphate ophthalmic solution;Prednisolone Acetate (1%) Eyedrops;100 mM sodium citrate buffer solution;Placebo Eyedrops
16 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis Completed NCT00407056 Phase 3 Difluprednate Ophthalmic Emulsion
17 Herpetic Eye Disease Study (HEDS) II Completed NCT00000139 Phase 3 Acyclovir
18 Study of Difluprednate in the Treatment of Uveitis Completed NCT00501579 Phase 3 Difluprednate;Prednisolone Acetate
19 A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis Completed NCT01148225 Phase 3 adalimumab
20 CLARITY Extension Study Completed NCT00641537 Phase 3 Cladribine;Placebo;Cladribine;Cladribine;Placebo
21 Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis Completed NCT03097315 Phase 3
22 Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis Completed NCT02595398 Phase 3 4mg CLS-TA Suprachoriodal Injection;Sham Procedure
23 A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Completed NCT02696785 Phase 3 Ixekizumab;Placebo;Adalimumab
24 SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis. Recruiting NCT03131154 Phase 3 ADX-102 Ophthalmic Solution (0.5%);Vehicle of ADX-102 Ophthalmic Solution
25 Treatment Tapering in JIA With Inactive Disease Recruiting NCT02840175 Phase 3 etanercept;adalimumab;Abatacept;Tocilizumab
26 A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Recruiting NCT03129100 Phase 3 Ixekizumab;Placebo
27 A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Active, not recruiting NCT02757352 Phase 3 Ixekizumab;Placebo
28 A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Active, not recruiting NCT02696798 Phase 3 Ixekizumab;Placebo
29 Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS Active, not recruiting NCT02552212 Phase 3
30 Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes Not yet recruiting NCT03586284 Phase 2, Phase 3 Valganciclovir Hydrochloride;Ganciclovir Sodium;Placebo Oral Tablet;Topical placebo
31 Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis Not yet recruiting NCT03576898 Phase 2, Phase 3 Topical ganciclovir versus oral valganciclovir versus placebo
32 A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis Terminated NCT00333996 Phase 2, Phase 3 Dexamethasone
33 Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis Completed NCT02482129 Phase 2 LME636 60 mg/mL ophthalmic solution;Dexamethasone 0.1% ophthalmic solution;LME636 Vehicle
34 A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis Completed NCT02406209 Phase 2 NS2;Prednisolone acetate ophthalmic suspension (1%)
35 Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis Completed NCT02309385 Phase 1, Phase 2 8% Dexamethasone Sodium Phosphate - Visulex;15% Dexamethasone Sodium Phosphate - Visulex;Prednisolone Acetate (1%) Eye Drops
36 Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis Completed NCT00823173 Phase 2
37 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed NCT00405496 Phase 2 Difluprednate Ophthalmic Emulsion
38 Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis Completed NCT00130637 Phase 2 Daclizumab
39 Topical Interferon Gamma for Macular Edema Secondary to Uveitis Completed NCT01376362 Phase 1, Phase 2 Interferon Gamma-1b
40 Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis Completed NCT00694135 Phase 2 EGP-437 1.6 mA-min at 0.4 with EyeGate® II System;EGP-437 4.8 mA-min at 1.2 mA with EyeGate® II System;EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System;EGP-437 14.0 mA-min at 3.5 mA with EyeGate® II System
41 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis Completed NCT02255032 Phase 2 4 mg CLS-TA;0.8 mg CLS-TA
42 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
43 A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis Withdrawn NCT00499551 Phase 1, Phase 2
44 Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti Completed NCT00876434 Phase 1 Sirolimus
45 Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions Withdrawn NCT02042027 Phase 1 Gamunex-C
46 Acute Anterior Uveitis: Psychic Burden and Pain Unknown status NCT01156285
47 Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis Unknown status NCT01486693
48 Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis Unknown status NCT02879084
49 Quality of Life and Visual Function in Uveitis Patients Unknown status NCT00407316
50 Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease Unknown status NCT00931957 Not Applicable Etanercept, Methotrexate, Prednisolone

Search NIH Clinical Center for Iridocyclitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: iridocyclitis

Sources

Genetic Tests for Iridocyclitis

About this section
Sources

Anatomical Context for Iridocyclitis

About this section

MalaCards organs/tissues related to Iridocyclitis:

41
Eye, Retina, Testes, Endothelial, Liver, Thyroid, Tongue
Sources

Publications for Iridocyclitis

About this section

Articles related to Iridocyclitis:

(show top 50) (show all 288)
# Title Authors Year
1
Fever of unknown origin, bilateral sensorineural hearing loss with canal paresis and uveitis with iridocyclitis and episcleritis: a case of Cogan's syndrome. ( 29703835 )
2018
2
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C. ( 30410728 )
2018
3
Moth-eaten appearance of the iris in Fuchs heterochromic iridocyclitis. ( 30447956 )
2018
4
Niemann-Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis. ( 29387679 )
2017
5
Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis. ( 28461535 )
2017
6
Intraocular Lymphoma Masquerading as Recurrent Iridocyclitis: Findings Based on in vivo Confocal Microscopy. ( 29099641 )
2017
7
The unusual association of inverse retinitis pigmentosa and Fuchs' heterochromic iridocyclitis. ( 28127443 )
2017
8
Leprosy Presenting with Iridocyclitis: A Diagnostic Dilemma. ( 29090057 )
2017
9
Zika virus-related hypertensive iridocyclitis. ( 26840174 )
2016
10
Risk Factors for Glaucoma in a Cohort of Patients with Fuchs Heterochromic Iridocyclitis. ( 27494676 )
2016
11
Phacoemulsification Versus Manual Small Incision Cataract Surgery in Patients With Fuchs Heterochromic Iridocyclitis. ( 26939115 )
2016
12
Recurrent iridocyclitis due to cotton fiber in anterior chamber. ( 28242892 )
2016
13
Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis. ( 27781126 )
2016
14
Bilateral acute iris transillumination (BAIT) initially misdiagnosed as acute iridocyclitis. ( 25945534 )
2015
15
Polymorphisms in cytomegalovirus genotype in immunocompetent patients with corneal endotheliitis or iridocyclitis. ( 25963863 )
2015
16
Analysis on the psychological characteristics of patients with acute iridocyclitis. ( 26086022 )
2015
17
Acute granulomatous iridocyclitis in a child with tubulointerstitial nephritis and uveitis syndrome. ( 25861394 )
2015
18
Fuch's Heterochromic Iridocyclitis in Iran: Is the Disease Going to Fade Away? ( 26730326 )
2015
19
Syphilis iridocyclitis in a patient with type 1 diabetes. ( 27180731 )
2015
20
Small-incision cataract surgery in patients with Fuch's heterochromic iridocyclitis. ( 25680261 )
2014
21
Herniation of the retina in the central macula in an adult after iridocyclitis. ( 26011975 )
2014
22
Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses. ( 25399915 )
2014
23
Implantation of iris-claw Artisan intraocular lens for aphakia in Fuchs' heterochromic iridocyclitis. ( 23571252 )
2014
24
Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population. ( 23514352 )
2013
25
Polymorphisms of TNFAIP3 Gene in a Chinese Han Population with Fuchs Heterochromic Iridocyclitis. ( 23463983 )
2013
26
Hypertensive iridocyclitis associated with delayed onset biopsy proven Cytomegalovirus retinitis. ( 23548320 )
2013
27
Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis. ( 23519886 )
2013
28
Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis. ( 22218256 )
2012
29
Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. ( 22898222 )
2012
30
Fuchs heterochromic iridocyclitis and the rubella virus. ( 21897135 )
2011
31
Adenoma of the nonpigmented ciliary epithelium presenting with recurrent iridocyclitis: unique expression of glial fibrillary acidic protein. ( 21088853 )
2011
32
Corneal astigmatism in unilateral Fuchs heterochromic iridocyclitis. ( 21595529 )
2011
33
Fuchs' heterochromic iridocyclitis associated with ocular toxocariasis. ( 21331701 )
2011
34
Bilateral acute depigmentation of the iris first misdiagnosed as acute iridocyclitis. ( 21633847 )
2011
35
Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. ( 20585798 )
2010
36
Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs Heterochromic Iridocyclitis. ( 20737053 )
2010
37
Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis. ( 20952847 )
2010
38
Confocal scan features of keratic precipitates in Fuchs heterochromic iridocyclitis. ( 19907293 )
2010
39
The possible role of systemic azithromycin for idiopathic iridocyclitis. ( 19891670 )
2010
40
Sarcoidosis presenting with massive splenomegaly in a child with a history of iridocyclitis and sensorineural deafness. ( 20615071 )
2010
41
Levocetirizine-induced iridocyclitis in a patient with allergic rhinitis. ( 20232781 )
2010
42
Retinal thickening in iridocyclitis. ( 19477710 )
2009
43
Fuchs heterochromic iridocyclitis--syndrome, disease, or both? ( 19782794 )
2009
44
Klebsiella pneumoniae endophthalmitis secondary to liver abscess presenting as acute iridocyclitis. ( 19772282 )
2009
45
Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and -negative eyes. ( 19463548 )
2009
46
Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. ( 19027423 )
2008
47
Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. ( 18435976 )
2008
48
Kinetics of aqueous flare, intraocular pressure and virus-DNA copies in a patient with cytomegalovirus iridocyclitis without retinitis. ( 17522780 )
2007
49
Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. ( 17631266 )
2007
50
When should intraocular lenses be implanted in patients with juvenile idiopathic arthritis-associated iridocyclitis? ( 17057416 )
2006
Sources

Variations for Iridocyclitis

About this section
Sources

Expression for Iridocyclitis

About this section
Search GEO for disease gene expression data for Iridocyclitis.
Sources

Pathways for Iridocyclitis

About this section

Pathways related to Iridocyclitis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Influenza A 37
Show member pathways
 11.61 HLA-B HLA-DPB1 TNFAIP3 TNFRSF10B
2
Epstein-Barr virus infection 37
11.44 HLA-B HLA-DPB1 TNFAIP3
Sources

GO Terms for Iridocyclitis

About this section

Cellular components related to Iridocyclitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ER to Golgi transport vesicle membrane GO:0012507 8.96 HLA-B HLA-DPB1
2 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 8.62 HLA-B HLA-DPB1

Biological processes related to Iridocyclitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 interferon-gamma-mediated signaling pathway GO:0060333 9.16 HLA-B HLA-DPB1
2 antigen processing and presentation GO:0019882 8.96 HLA-B HLA-DPB1
3 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042 8.62 TNFAIP3 TNFRSF10B

Molecular functions related to Iridocyclitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 8.62 HLA-B HLA-DPB1
Sources

Sources for Iridocyclitis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....